Clinical Trials Logo

Malignant Meningioma clinical trials

View clinical trials related to Malignant Meningioma.

Filter by:
  • None
  • Page 1

NCT ID: NCT01151670 Completed - Clinical trials for Glioblastoma Multiforme

Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain Tumors

Start date: August 2010
Phase: Phase 1
Study type: Interventional

RATIONALE: Pioglitazone hydrochloride may be effective treatment for cognitive dysfunction caused by radiation therapy. PURPOSE: This phase I trial is studying the side effects and best dose of pioglitazone hydrochloride in preventing radiation-induced cognitive dysfunction in treating patients with brain tumors.

NCT ID: NCT01144247 Completed - Clinical trials for Glioblastoma Multiforme

Cellular Immunotherapy Study for Brain Cancer

alloCTL
Start date: July 2010
Phase: Phase 1
Study type: Interventional

The purpose of this research study to determine if treating recurrent malignant gliomas with another person's (donor) immune system cells known as aCTL cells, will be safe. This study will also try to determine if persons who receive aCTL's are more or less likely to survive their brain tumor than persons who had similar tumors in the past. Approximately 15 patients will be enrolled at UCLA.